Z. Veitch

Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer.

X. Kostaras, P. Tang, K. King, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance

Adam J. Bewick, D. MacLean, Baoqing Guo, 2009, Pharmacogenetics and genomics.

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

S. Sridhar, S. North, Z. Veitch, 2022, Therapeutic advances in medical oncology.

Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study

T. H. van der Kwast, A. Zlotta, A. Finelli, 2021, PloS one.

Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis

A. Scheer, L. Paszat, Kuan Liu, 2022, Breast Cancer Research and Treatment.

Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis

A. Scheer, L. Paszat, Kuan Liu, 2022, Breast Cancer Research and Treatment.

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

Baoqing Guo, S. Hembruff, A. Parissenti, 2008, BMC Cancer.

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Bingshu E. Chen, A. Tinker, H. Feilotter, 2022, Nature Communications.

Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade

H. Goldvaser, A. Ocaña, E. Amir, 2021, Scientific Reports.